Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Liver Research Institute
8 active people
4 grants
Recent Grants
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
2023
·
$1.6M
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate
2023
·
$641.6K
clinical trial,
drug therapy,
liver disease,
biomarker,
immunology
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis
2022
·
$258.5K
clinical trials,
liver disease,
drug efficacy,
safety evaluation,
therapeutic intervention
Blood-to-CNS Drug Uptake in Pain
2009
·
$2.5M
drug uptake,
blood-brain barrier,
pain management,
central nervous system,
pharmacokinetics
People
Andrea Madrigal-Diaz
Clinical Research Coordinator I
Joshua Gaddy
Clinical Research Coordinator II
Jason Gass
Research Data Support Specialist II
Ryan Akhbari
Clinical Research Coordinator II
Robert Kuester
Researcher/Scientist III
Lucia Felix
Community Outreach Assistant III
Marc Oshiro
Researcher/Scientist III
Maria Santa Cruz
Clinical Research Coordinator II